INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

ExodusPoint Capital Management, LP's Holding History (CIK: 0001736225)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 35,087 Value ($000) $1 Avg Close Range
Q2 2023
Shares 141,219 Value ($000) $2 Avg Close Range
Q1 2023
Shares 77,558 Value ($000) $1 Avg Close Range
Q4 2022
Shares 530,567 Value ($000) $7 Avg Close Range
Q3 2022
Shares 83,939 Value ($000) $1,171 Avg Close Range
Q1 2022
Shares 34,745 Value ($000) $565 Avg Close Range
Q4 2021
Shares 157,663 Value ($000) $2,568 Avg Close Range
Q3 2021
Shares 28,633 Value ($000) $425 Avg Close Range
Q2 2021
Shares 10,635 Value ($000) $212 Avg Close Range
Q1 2021
Shares 18,055 Value ($000) $417 Avg Close Range
Q4 2020
Shares 18,929 Value ($000) $468 Avg Close Range
Q2 2020
Shares 40,941 Value ($000) $1,961 Avg Close Range
Q2 2019
Shares 3,400 Value ($000) $271 Avg Close Range
Q1 2019
Shares 1,796 Value ($000) $201 Avg Close Range